Skip to main content

Clinical Research Studies: Data Table 4

Note: All values are from data submitted annually by centers.

The following tables compare the number of open trials and number of patients accrued to open trials for all NCI-Designated Cancer Centers combined.

Number of Trials and Patients Accrued Categorized by Fiscal Year and Study Source

Study Source Open Trials Patient Accrued
Total Number Median Total Number Median
Industry 7,544 106 26,580 323
External Peer Reviewed 2,330 35 105,486 600
Institutional 7,375 93 195,477 1,378
National Cooperative Group 5,796 95 13,416 165
Other/Unknown 705 11 198,686 18
Total 23,750 539,645

Number of Trials and Patients Accrued by Clinical Research Category Categorized by Fiscal Year and Clinical Research Category

Research Category Open Trials Patient Accrued
Total Number Median Total Number Median
INT 17,635 256 104,869 1,199
OBS 3,177 46 362,410 735
ANC/COR 2,925 33 72,275 510
N/A 13 1 91 0
Total 23,750 539,645

Number of Trials and Patients Accrued Categorized by Fiscal Year and Phase

Phase Open Trials Patient Accrued
Total Number Median Total Number Median
0 79 2 680 30
I 3,098 42 10,976 104
I/II 1,654 22 6,245 69
II 5,731 85 22,037 215
II/III 444 7 959 9
III 4,549 72 17,072 177
III/IV 12 1 270 11
IV 128 2 720 5
IV/V 1 1 29 29
Pilot/Feasibility 1,456 22 16,157 144
N/A 6,598 84 464,500 2,116
Total 23,750 539,645

Number of Trials and Patients Accrued Categorize by Fiscal Year and Primary Purpose

Primary Purpose Open Trials Patient Accrued
Total Number Median Total Number Median
BAS 2,412 25 65,147 421
DIA 823 10 12,076 110
HSR 358 4 202,673 59
PRE 439 6 28,132 90
SCR 307 4 16,045 106
SUP 1,051 15 14,287 134
TRE 15,558 236 51,242 595
OTH 2,802 40 150,043 650
Total 23,750 539,645
Last Updated
April 30, 2024